Form 4 for EDVA Endovia Health Sciences, Inc.
Accepted 2023-04-13 00:00:00 ET · period of report 2023-04-13 · accession 0001731122-23-000644 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-04-13 | 2023-04-13 | EDVA | Nistico Robert | CEO, COB, Dir | P - Purchase | $1.17 | +17.0K | 1.36M | +1% | +$19.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-13 | P | A | 10,000 | $1.17 | 1,367,000 | D | — | — | |
| 2 | Common | Common Stock | 2023-04-13 | P | A | 7,000 | $1.17 | 1,357,000 | D | — | — |